EcoDrugPlus

Casein Kinase 1, Epsilon

Ensembl ID : ENSIPUG00000001538
Gene Symbol: CSNK1E
4 Cross references
211 Possible Orthologues:

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSIPUG00000019414
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase A

Ensembl ID : ENSIPUG00000012075
Gene Symbol: LOC108265311
3 Cross references
212 Possible Orthologues:

Catechol-O-Methyltransferase A

Ensembl ID : ENSIPUG00000012058
Gene Symbol: LOC108265311
3 Cross references
212 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSIPUG00000002552
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSIPUG00000006846
Gene Symbol: CTSK
3 Cross references
236 Possible Orthologues:

Cathepsin S, Ortholog2, Tandem Duplicate 1

Ensembl ID : ENSIPUG00000006902
Gene Symbol: CTSS2.1
2 Cross references
235 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSIPUG00000013306
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Cellular Tumor Antigen P53

Ensembl ID : ENSIPUG00000019605
Gene Symbol: LOC108267915
3 Cross references
232 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSIPUG00000001680
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSIPUG00000015587
Gene Symbol: CHEK2
3 Cross references
205 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSIPUG00000002370
Gene Symbol: CCR9A
4 Cross references
188 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).